Bulletin
Investor Alert

Topics

Science and Technology

Video

The Group Teaching Coding in Prison

  • The Group Teaching Coding in Prison The Group Teaching Coding in Prison 2:43
    Giving Old Computers the 'Spit-Shine' Giving Old Computers the 'Spit-Shine' 2:32
    Inflatable ICU: South Korea's Answer to Potential Covid-19 Bed Shortages Inflatable ICU: South Korea's Answer to Potential Covid-19 Bed Shortages 4:40
    Why TikTok Has Become a Launchpad for Entrepreneurs Why TikTok Has Become a Launchpad for Entrepreneurs 6:39
10:49 a.m. Today - By Michael E. Mann
We can’t solve the climate crisis without getting out of our cars and onto buses and trainsImproving public transportation helps the U.S. economy and the planet.
9:57 a.m. Today - By Jurica Dujmovic
You will not be traveling in a self-driving car anytime soon. Here's what the future will look like It will take many years for researchers to optimize autonomous driving. Those improvements can't be rushed.
3:59 a.m. Today - By Jaimy Lee
Is it time for Americans to drop their infatuation with the PCR test and start using more rapid tests? That's what this COVID-19 testing expert thinksDr. Michael Mina is an assistant professor of epidemiology at the Harvard T.H. Chan School of Public Health.
3:55 a.m. Today - By Jaimy Lee
Regeneron says its COVID-19 antibody treatment cuts the risk of death among hospitalized patientsShares of Regeneron Pharmaceuticals Inc. gained 0.1% in premarket trading on Wednesday after the company said its COVID-19 antibody therapy cut the risk of death in patients who have been hospitalized by 20%. This is the first time clinical research has demonstrated that Regeneron's antibody treatment has improved survival for hospitalized patients. The study, which is being conducted in the U.K. in patients who have not yet developed antibodies, follows other research that showed the company's antibody treatment can improve recovery times among people with mild or moderate forms of the disease. Regeneron said it is planning to ask the Food and Drug Administration to expand the emergency-use authorization in the U.S. to include these types of patients. Regeneron's stock is up 9.2% so far this year, while the broader S&P 500 has gained 13.0%.
2:00 a.m. Today - Barrons.com
America Is Giving Away Millions of Vaccine Doses. It's Not Enough. Vaccine sharing needs to be a sustained part of America's pandemic response, writes Michelle McMurry-Heath.
8:34 p.m. June 15, 2021 - MarketWatch.com
China set to send inaugural crew to its new space station on Thursday for three-month stayBeijing doesn't participate in the International Space Station, largely due to U.S. concerns over the Chinese program's secrecy and its military connections.
9:07 a.m. June 15, 2021 - By Victor Reklaitis
House works to advance legislation aimed at countering China's tech boom A measure aimed at aiding the U.S. semiconductor industry and other high-tech sectors might end up getting signed into law by President Joe Biden this summer --- earlier than initially expected.
9:03 a.m. June 15, 2021 - By Jaimy Lee
New NIH study says the coronavirus was present in five states in December 2019A new study conducted by the federal government indicates that people in several U.S. states were infected with SARS-CoV-2 in the U.S. earlier than previously thought, based on an analysis of blood donations. At least nine people in Illinois, Massachusetts, Mississippi, Pennsylvania, and Wisconsin demonstrated that they had developed COVID-19 antibodies in early January 2020, according to the National Institutes of Health , published Tuesday in the journal Clinical Infectious Diseases. Federal health officials of COVID-19 in the U.S. on Jan. 21, 2020. The NIH researchers examined 24,000 blood samples from 50 states between Jan. 2 and March 18, 2020. Because the antibodies were detected on Jan. 7 and 8 of that year, that means the virus was present in those states in December. (Antibodies take about two weeks to develop.)
7:16 a.m. June 15, 2021 - By Jeremy Michalek
I'm an EV expert, and I'm skeptical about how quickly electric cars will go mainstream in the U.S.The pace of adoption for electric vehicles is more complex than just how quickly battery prices fall.
5:36 a.m. June 15, 2021 - By Jaimy Lee
Novavax says efficacy of COVID-19 vaccine isn't affected when co-administered with the flu shotShares of Novavax Inc. were down 0.9% in trading on Tuesday, the day after the company said a study evaluating co-vaccination against COVID-19 and the flu demonstrated similar efficacy to administering Novavax's experimental COVID-19 shot alone. "Separate health care visits to cover both COVID-19 and influenza vaccinations will be burdensome," a Novavax executive said in a news release. As part of the Phase 3 clinical trial for its coronavirus vaccine in the U.K., the company also enrolled 431 participants in a sub-study that gave participants both the COVID-19 vaccine and the flu shot. In the , published Sunday, the researchers found that the immunogenicity of the flu shot was the same, while there was a "modest decrease" in the immunogenicity of the COVID-19 shot. Novavax also announced this week that its coronavirus vaccine when it comes to preventing symptomatic infection in roughly 30,000 participants enrolled in the Phase 3 clinical trial in the U.S. Novavax's stock has soared 86.2% so far this year, while the S&P 500 is up 13.3%.
4:52 a.m. June 15, 2021 - By Jaimy Lee
Biogen says experimental drug for rare retinal disease fails in late-stage clinical trial Shares of Biogen Inc. were down 0.3% in premarket trading on Tuesday, the day after the company said an experimental gene therapy for choroideremia failed a late-stage clinical trial. Biogen said Monday that the Phase 3 study did not meet its primary endpoint or efficacy on secondary endpoints among study participants who have the rare, hereditary retinal disease. The news is one of several stock-moving announcements for Biogen in the last two weeks, including the Food and Drug Administration last week and Tuesday's disclosure that an experimental treatment for major depressive disorder it's developing with Sage Therapeutics Inc. in a Phase 3 clinical trial. Biogen's stock is up 65.8% so far this year, while the S&P 500 has gained 13.3%.
4:35 a.m. June 15, 2021 - Barrons.com
The E3 Videogame Show's Top Announcements So Far Microsoft made the upcoming Starfield an Xbox and PC exclusive, a much anticipated move after it acquired the owner of developer Bethesda. Ubisoft surprised by unveiling a collaboration with Nintendo.
3:51 a.m. June 15, 2021 - Barrons.com
Dimon Is Betting Inflation Fears Will Return Vaccinations offer protection against concerning Delta variant, Biden calls NATO alliance “rock-solid,” Americans are keeping their cars longer, and other news to start your day.
4:42 a.m. June 14, 2021 - By Jaimy Lee
iTeos stock jumps 60% after company announces deal with GSKShares of iTeos Therapeutics Inc. soared 58.5% in premarket trading on Monday after the company announced a deal with GlaxoSmithKline to develop and commercialize an experimental cancer therapy. GSK will make a $625 million upfront payment to iTeos, with an additional $1.4 billion in possible milestone payments available in the future. The immuno-oncology drug candidate is currently being tested in an open-label, Phase 1 clinical trial in patients with advanced solid tumors; as part of this deal, the companies plan to pair the iTeos drug with GSK's Jemperli in studies next year. (Jemperli was initially approved by the Food and Drug Administration as a treatment for endometrial cancer in April.) Shares of iTeos are down 40.8% so far this year, while the S&P 500 has gained 13.1%.
4:28 a.m. June 14, 2021 - By Jaimy Lee
Moderna hires J&J executive as chief medical officerShares of Moderna Inc. were down 2.1% in premarket trading on Monday after the company said it hired Dr. Paul Burton as its new chief medical officer. Burton, a former Johnson & Johnson executive, will report to CEO Stéphane Bancel. He replaces Dr. Zal Taks, who announced plans to leave Moderna earlier this year. Burton most recently was the chief of global medical affairs for J&J's pharmaceuticals business. Both Moderna and J&J have received authorizations for their COVID-19 vaccines in the U.S. Moderna's stock is up 109.5% so far this year, while the broader S&P 500 has gained 13.1%.
4:42 p.m. June 13, 2021 - MarketWatch.com
Winning ticket to fly in space with Jeff Bezos costs $28 millionAn auction for a ride into space next month alongside Jeff Bezos and his brother ended with a winning $28 million bid Saturday.
9:12 a.m. June 12, 2021 - By Brett Arends
Only 'greedy' drug companies will cure Alzheimer'sWhy should people invest in companies making lifesaving drugs when they can make more in booze and cigarettes?
8:08 a.m. June 12, 2021 - By Philip van Doorn
We put 6 more meme stocks' numbers to the test and the differences are tellingDigging deeper into the the meme stock phenomenon, there are big difference between Palantir, Wendy's, Canoo and other companies.
5:57 a.m. June 12, 2021 - By Tomi Kilgore
New U.S. COVID-19 cases and deaths jump to two weeks highsThe number of new daily COVID-19 cases and deaths jumped to the highest levels in more than two weeks, as the daily vaccination rate continues to suggest President Biden's goal won't be met.
5:37 a.m. June 12, 2021 - MarketWatch.com
YouTube suspends GOP Sen. Ron Johnson for 7 days over COVID treatment videoYouTube has blocked Sen. Ron Johnson (R-Wis.) from uploading videos for seven days over clips the platform said violated its COVID-19 “medical misinformation policies.”
11:03 a.m. June 11, 2021 - By Tomi Kilgore
New daily COVID-19 cases and deaths fall for first time in 4 days, while vaccine concerns grow with reports of side effectsThe number of new daily COVID-19 cases and deaths fell for the first time in four days, but vaccine hesitancy, amid reports of a heart inflammation side effect in teens and some supply concerns, is increasing the risk that President Biden's vaccination goal may not be reached.
7:13 a.m. June 11, 2021 - By Steve Goldstein
Is this the Manchin rally? Bonds are rising and stocks at record high as spending expectations waneYou wouldn't expect stocks and bonds to rise after a hotter-than-forecast inflation reading in a market that has been obsessed with the I-word, yet that's what happened on Thursday.
4:46 a.m. June 11, 2021 - By Tomi Kilgore
Vertex Pharmaceuticals stock tumbles to pace S&P 500 losers after disappointing drug trial dataShares of Vertex Pharmaceuticals Inc. tumbled 13.8% in premarket trading Friday, enough to pace the S&P 500's early decliners, after the biotechnology company released what was seen as disappointing data on its treatment for people with alpha-1 antitrypsin deficiency (AATD), which can lead to liver and lung disease. The stock was on track to open at the lowest price seen during regular-session hours since October 2019. The company said late Thursday that , showing a mean increase of 2.2 to 2.3 micromolar fAAT levels across the dose groups compared with placebo. Analyst Cory Kasimov at J.P. Morgan reiterated his overweight rating but cut his stock price target to $245 from $279, saying the trials results were "clearly" a setback. "Management is adamant that this is actually a step in the right direction for the program," Kasimov wrote. "We doubt [Wall Street] will agree." Stifel Nicolaus's Paul Matteis cut his stock price target to $244 from $277: "The announcement of modest AAT increases for VX-864, despite what looked like great data in animals, makes it difficult for us to garner conviction that futures compounds will perform materially better." The stock has lost 8.3% year to date, while the S&P 500 has climbed 12.9%.
3:55 a.m. June 11, 2021 - By Tomi Kilgore
Orphazyme stock losing half its value premarket, after rocketing fourfold the day beforeShares of Orphazyme A/S plunged 50.2% in active premarket trading Friday, , after the Denmark-based biopharmaceutical company said overnight that wasn't aware of any reason for the recent "extreme volatility." Trading volume was already up to 4.1 million shares before Friday's open, compared with the full-day average over the past 30 days of about 286,000 shares, according to FactSet On Thursday, the stock had soared as much 1,387% intraday before closing up 301.5% on volume of 7.9 million shares, and was halted a total of 22 times for volatility during the day. "The company is not aware of any material change in its clinical development programs, financial condition or results of operations that would explain such price volatility or trading volume that has occurred since June 10, 2021," the company said in a statement. "Investors who purchase the company's ADS or shares may lose a significant portion of their investments if the price of such securities subsequently declines." The company's applications for arimoclomol for Niemann-Pick disease type C are under priority review with the U.S. Food and Drug Administration, with an expected action date of June 17. Even with the previous day's surge, the stock has gained 62.9% over the past three months through Thursday, while the S&P 500 has gained 7.6%.
2:50 a.m. June 11, 2021 - By Tomi Kilgore
Coronavirus tally: New daily COVID-19 cases falls in the U.S. to snap 3-day streak of increasesThe global tally for the coronavirus-borne illness continued its climb to 174.89 million on Friday, , while deaths increased to 3,774,138. The U.S. led the world in total cases at 33.43 million, while deaths totaled 598,748. The new reported daily cases of COVID-19 fell to 11,841 on Thursday from 20,153 the day before, , to mark . New deaths fell to 412 on Thursday from 449 on Wednesday. The seven-day average of cases slipped to 13,409, down 42% from two weeks ago, while the average for deaths declined to 387, which is 22% below where it was two weeks ago. The number of fully vaccinated Americans rose to 141.58 million, or 42.6% of the total population, according to , with the number of U.S. adults receiving at least one dose increasing to 64.0%. On a global basis, India was second in total cases at 29.27 million on Wednesday, followed by Brazil at 17.21 million, according to JHU data, while Brazil was second in deaths at 482,019 and India was third at 363,079.
11:26 a.m. June 10, 2021 - Barrons.com
The Group Teaching Coding in PrisonAn organization started in San Quentin State Prison is teaching incarcerated people coding and tech skills to make it easier for them to find solid jobs. The Last Mile is a 2021 Barron's Celebrates honoree.
10:47 a.m. June 10, 2021 - By Tomi Kilgore
New daily COVID-19 cases rise back above 20,000, as cases and deaths increase for 3rd straight dayWhile Americans have been rejoicing over the return to near-normalcy, the number of new daily cases and deaths of the coronavirus-borne illness rose for a third-straight day, with cases topping the 20,000 mark for the first time in over a week.
2:21 a.m. June 10, 2021 - By Tomi Kilgore
Coronavirus tally: U.S. new daily cases rise back above 20,000The global tally for the coronavirus-borne illness climbed to 174.46 million on Thursday, , while deaths increased to 3,759,039. The U.S. led the world in total cases at 33.41 million, while deaths rose closer to the 600,000 mark, reaching 598,765. The new reported daily cases of COVID-19 rose to 22,314 on Wednesday from 15,059 the day before, , the highest daily total since June 1, as new deaths were at least increased to 449 on Wednesday from Tuesday's 373. The seven-day average of cases edged up to 14,809, down 36% from two weeks ago, while the average for deaths slipped to 417, which is 20% below where it was two weeks ago. The number of fully vaccinated Americans rose to 140.98 million, or 42.5% of the total population, according to , with the number of U.S. adults receiving at least one dose increased to 63.9%. On a global basis, India was second in total cases at 29.18 million on Wednesday, followed by Brazil at 17.12 million, according to JHU data, while Brazil was second in deaths at 479,515 and India was third at 355,705.
12:32 p.m. June 9, 2021 - By Jack Denton
This robot-run fund thinks GameStop stock will soar in June, and predicts a fall for Tesla and AmazonAn exchange-traded fund driven by artificial intelligence booted Tesla and Amazon from its portfolio in June, instead choosing to load up on shares of companies including Qualcomm, Snap and GameStop.
11:38 a.m. June 9, 2021 - By Tomi Kilgore
New daily COVID-19 cases and deaths rise again as concerns over delta variant and Biden vaccination target for July 4 increaseThe number of new daily COVID-19 cases and deaths rose for a second straight day, as concerns over the more easily transmissible delta variant increase, and as continued vaccination hesitancy puts meeting President Biden's goal at risk.
5:15 a.m. June 9, 2021 - By Victor Reklaitis
Senate passes bill that targets China and chips in 68-32 voteThe Democratic-run Senate, with some Republican support, passes legislation on Tuesday that targets China and aims to support the American semiconductor industry, in a sign there's bipartisan agreement on how to handle Beijing and a key U.S. sector.
3:40 a.m. June 9, 2021 - By Tomi Kilgore
Coronavirus tally: Global cases to 174 million, while fully vaccinated in U.S. tops 140 million peopleThe global tally for the coronavirus-borne illness rose to 174.04 million on Wednesday, , while deaths increased to 3,748,866. The U.S. was the global leader in total cases at 33.39 million, while deaths rose closer to the 600,000 mark, reaching 598,330. The seven-day average for cases in the U.S. was 14,031 as of Tuesday, down 42% from two weeks ago, , while the daily average for deaths fell 20% to 438. The declines in cases and deaths come as the number of fully vaccinated Americans rose to 140.44 million, or 42.3% of the total population, according to . On a global basis, India was second in total cases at 29.09 million on Wednesday, followed by Brazil at 17.04 million, according to JHU data, while Brazil was second in deaths at 476,792 and India was third at 353,528.
7:54 p.m. June 8, 2021 - By Mike Murphy
Here's everything new coming to Netflix in June 2021 -- and what's leaving'Lupin,' 'Elite' and 'Kim's Convenience' return, along with new movies from Kevin Hart, Gina Rodriguez and Liam Neeson
11:41 a.m. June 8, 2021 - By Paul Brandus
A big step toward beating Alzheimer’s—but the battle is far from overA true cure for Alzheimer's can't come fast enough
10:15 a.m. June 8, 2021 - Barrons.com
Giving Old Computers the 'Spit-Shine'Based out of St. Paul, Minn., PCs for People refurbishes computers for people who can't afford new ones. The organization is a 2021 Barron's Celebrates honoree.
10:04 a.m. June 8, 2021 - By Tomi Kilgore
New U.S. COVID-19 cases and deaths tick higher, while CDC's 'real world' study shows Pfizer, Moderna vaccines reduce infection risk by 91%The number of new daily COVID-19 cases and deaths in the U.S. ticked higher, but was still down significantly over the past couple weeks, as more than two of every five Americans are now fully vaccinated.
5:14 a.m. June 8, 2021 - MarketWatch.com
Government, news and commercial websites affected as Fastly outage causes large-scale global internet disruptionDozens of sites including the New York Times, CNN, some Amazon sites, Twitch, Reddit, the Guardian and the U.K. government's home page could not be reached.
3:43 a.m. June 8, 2021 - By Tomi Kilgore
Biogen stock rockets to 6-year high after Alzheimer's drug gets FDA OKShares of Biogen Inc. rocketed to a six-year high in volatile trading Monday, as Wall Street analysts cheered the U.S. Food and Drug Administration's broad labeling that came with the approval of the biotechnology company's Alzheimer's drug.
3:39 a.m. June 8, 2021 - By Tomi Kilgore
Coronavirus tally: Global cases rise to 173.7 million, while U.S. daily cases and deaths keep trending lowerThe global tally for the coronavirus-borne illness rose to 173.67 million on Tuesday, , while deaths increased to 3,738,417. The U.S. was the global leader in total cases at 33.38 million, while deaths crept closer to the next grim milestone, as they reached 597,983. Meanwhile, the seven-day average for cases was 15,091 as of Monday, down 39% from two weeks ago, , while the daily average for deaths fell 19% to 459. The declines in cases and deaths come as the number of fully vaccinated Americans rose to 139.75 million, or 42.1% of the total population, . On a global basis, India was second in total cases at 29.00 million on Tuesday, followed by Brazil at 16.98 million, according to JHU data, while Brazil was second in deaths at 474,414 and India was third at 351,309.
1:36 p.m. June 7, 2021 - By Rachel Koning Beals
Why the rush to curb climate change? Damaging carbon dioxide is 50% higher than at the dawn of the industrial eraThe annual peak of heat-trapping carbon dioxide in the air has hit another milestone: 50% higher than when the industrial age began.
Browse topics:

Filter results by

Location

Us (552)

Europe (113)

Asia Pacific (100)

Eu (80)

China (76)

Uk (22)

Link to MarketWatch's Slice.